CN Patent

CN103316026B — 含芬特明和托吡酯的联合产品及其制备方法

Assigned to Institute of Pharmacology and Toxicology of AMMS · Expires 2016-05-11 · 10y expired

What this patent protects

本发明提供了一种联合产品，其中含有芬特明速释微丸和托吡酯的缓释微丸，其中托吡酯微丸包含：a.空白丸芯；b.不含粘合剂只含托吡酯的活性药物层，该层位于空白丸芯的表面；c.含有乙基纤维素和PVP？K30的缓释包衣层，该缓释包衣层位于活性药物层的外部。本发明还公开了制备该联合产品的方法。

USPTO Abstract

本发明提供了一种联合产品，其中含有芬特明速释微丸和托吡酯的缓释微丸，其中托吡酯微丸包含：a.空白丸芯；b.不含粘合剂只含托吡酯的活性药物层，该层位于空白丸芯的表面；c.含有乙基纤维素和PVP？K30的缓释包衣层，该缓释包衣层位于活性药物层的外部。本发明还公开了制备该联合产品的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN103316026B
Jurisdiction
CN
Classification
—
Expires
2016-05-11
Drug substance claim
No
Drug product claim
No
Assignee
Institute of Pharmacology and Toxicology of AMMS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.